Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-12 2:45 pm Purchase | 13G | ARRIVENT BIOPHARMA INC AVBP | Sofinnova Venture Partners XI L.P. | 1,696,752 5.100% | 1,696,752 (New Position) | View |
| 2024-09-30 8:34 pm Purchase | 13D | BIOAGE LABS INC BIOA | Sofinnova Venture Partners XI L.P. | 2,304,901 6.700% | 2,304,901 (New Position) | View |
| 2024-06-14 3:59 pm Purchase | 13D | Rapport Therapeutics Inc. RAPP | Sofinnova Venture Partners XI L.P. | 1,951,562 5.500% | 1,951,562 (New Position) | View |